Polyrizon ltd PLRZ.US Overview Analysis
PLRZ AI Analysis Overview
Keys for Bullish View
- Value≥4
- Dividend≥2
Analysis Conclusion
With insufficient quarterly financial data released by the company, we're unable to provide a rating.
PLRZ Current Performance
-33.46%
Polyrizon ltd
-3.92%
Avg of Sector
-0.77%
S&P500
Top 10 High Relevance to PLRZ
- RGLS Regulus therapeutics incorporatedValue 3Trend 5Swing Trading 2Whale Interest 1Dividend 1See more
PLRZ Profile
Polyrizon Ltd is an Israel-based biotechnology company. The Company is primarily engaged and specializing in the development of medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. Its naturally occurring building blocks, is delivered in the form of nasal sprays, and potentially functions as a biological mask with a thin shield containment barrier in the nasal cavity. The Company is focused not only on the development of intranasal products, but also on commercialization. The Company cooperates with medical specialists and researchers..